Abstract:
The present invention provides an isolated and substantially purified recombinant human arginase having sufficiently high enzymatic activity and stability to maintain Adequate Arginine Depletion in a patient. The present invention also provides a pharmaceutical composition comprising the modified invention enzyme and method for treatment of diseases using the pharmaceutical composition.
Abstract:
Methods and apparatuses for color denoising are described. There is provided an image processing method. The method comprises the steps of retrieving chrominance level for a plurality of pixels in a predetermined configuration; computing a weight for each pixel; applying the weight to the chrominance level for each the pixel; summing the weighted chrominance level to output a chrominance level for a centre pixel at the center of said predetermined configuration; and repeating the above steps for every pixel per image. The color noise can be reduced while preserving the edge without any edge detection.
Abstract:
The present invention provides a system and method for enabling the dynamic generation of user interface components. The dynamically-generated user interface components are based on templates and mappings that can be predefined through interaction with a user interface.